What is N-Acetyl Selank?
N-Acetyl Selank — sometimes written NA-Selank — is a synthetic peptide closely related to Selank. Think of it as Selank with a small chemical "cap" added to one end. That cap is an acetyl group (a tiny carbon-based tag), and it changes how the molecule behaves in the body. The original Selank was developed in Russia and is derived from a naturally occurring fragment of a protein called tuftsin. N-Acetyl Selank carries all the structural features of its parent compound, but the acetylation is thought to improve its stability and how well it crosses biological barriers. It is currently classed as a research compound, meaning it is studied in laboratory and preclinical settings — it is not approved for human use as a medicine.
How N-Acetyl Selank Works
Here is a simple way to picture it. Your brain runs on a careful balance of chemical messengers — some that calm activity down, some that ramp it up. One of the most important "calm-down" messengers is called GABA. Anxiety, in part, happens when that calming system is underactive. Selank and its acetylated cousin are thought to interact with the same family of receptors that GABA targets — the GABA-A receptor family — nudging the brain's natural brake pedal without hitting it as hard as a sedative drug would.
Beyond that, the Selank family has been studied for its potential effects on another key messenger system: serotonin. Serotonin influences mood, sleep, and how we respond to stress. Researchers have also looked at whether these peptides affect BDNF — brain-derived neurotrophic factor — a protein that acts like fertilizer for brain cells, helping them survive and form new connections. The acetyl modification in N-Acetyl Selank may slow the peptide's breakdown, meaning it could stay active in the body longer than standard Selank before enzymes chew it apart.
What the Research Shows
Because no numbered sources are available on this page, the following reflects the general body of preclinical and early-stage research on the Selank peptide family, of which N-Acetyl Selank is a structural variant.
- Anxiety-related behavior: Animal studies on Selank and closely related analogs have repeatedly observed reductions in anxiety-like behavior using standard laboratory tests, such as the elevated plus maze — a simple arena where a rodent's willingness to explore open, exposed areas signals lower anxiety.
- Cognitive and memory effects: Preclinical work has explored whether Selank-type peptides support learning and memory consolidation, with some studies pointing to improvements in recall tasks in animal models.
- Immune and inflammatory markers: Some research has looked at whether these peptides influence cytokines — small proteins that coordinate immune responses — suggesting possible anti-inflammatory activity, though this work is preliminary.
- Tolerability profile: In the studies that have been conducted, Selank-family peptides have generally shown a mild side-effect profile compared to classical anxiolytic drugs like benzodiazepines, without the sedation or dependence signals seen with those agents.
It is important to stress: research on N-Acetyl Selank specifically is early-stage. Most of the evidence base comes from work on Selank itself. Whether the acetyl modification meaningfully changes outcomes in humans remains an open research question.
What N-Acetyl Selank Is Being Studied For
Researchers are most interested in N-Acetyl Selank in the following areas:
- Anxiolysis — reducing anxiety-like states without heavy sedation
- Cognitive enhancement — supporting memory, focus, and information processing
- Stress resilience — how the peptide might modulate the body's stress-response systems
- Neuroprotection — whether BDNF-related activity could help protect neurons under stress or injury conditions
- Mood regulation — links to serotonin pathways make it a candidate for mood-related research
None of these applications have reached the stage of approved clinical use. All work is investigational.
How N-Acetyl Selank Is Dosed in Research
Dosing in peptide research is highly context-dependent — it varies by the model being studied, the route of administration, the research question, and many other factors. Rather than quoting single numbers here, we encourage you to consult the dosage chart on this page, which summarizes the ranges reported across preclinical studies, and use the on-page calculator to work through weight-based calculations for your research protocol. Always design dosing within an approved institutional or regulatory framework.
Mixing and Storing N-Acetyl Selank
N-Acetyl Selank typically arrives as a lyophilized (freeze-dried) powder in a sealed vial. To reconstitute it, researchers add bacteriostatic water — water that contains a small amount of benzyl alcohol to prevent bacterial growth — slowly and along the inside wall of the vial rather than directly onto the powder. Squirting water straight at the peptide cake can damage the delicate molecular structure. Gently swirl; do not shake vigorously. Once mixed, the solution should be stored in a refrigerator (around 2–8 °C) and kept away from light. Reconstituted peptide solutions are generally considered stable for a few weeks under refrigeration, though for long-term storage the dry, unreconstituted powder kept frozen is preferable. Always label your vial with the date of reconstitution and the concentration you prepared.
EN
BR
ES
FR
DE
RU